Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme

Trends in Parasitology

Volumn 22, Issue 7, 2006, Pages 340-344

  Mohammed, Khalfan A ^a   Molyneux, David H ^b   Albonico, Marco ^c   Rio, Francesco ^d  

^a Ministry of Health Zanzibar   (Tanzania)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c Ivo de Carneri Foundation   (Italy)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIFILARIAL AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; DIETHYLCARBAMAZINE; IVERMECTIN;

AFRICA; DIARRHEA; DRUG DISTRIBUTION; EGYPT; ERADICATION THERAPY; FILARIASIS; HEADACHE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; LYMPHEDEMA; NAUSEA; POLITICS; PREVALENCE; PRURITUS; REVIEW; SKIN INFECTION; SOCIAL ASPECT; STOMACH DISEASE; TANZANIA; VOMITING; WUCHERERIA BANCROFTI;

ANIMALS; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; FILARICIDES; HUMANS; NATIONAL HEALTH PROGRAMS; TANZANIA;

WUCHERERIA BANCROFTI;

EID: 33745662637     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2006.05.010     Document Type: Review

References (22)

1. Michael E., and Bundy D.A. Global mapping of lymphatic filariasis. Parasitol. Today 13 (1997) 472-476
2. WHO (1995) In World Health Report 1995: Bridging the Gaps, p. 118.2, WHO, Geneva
3. ITFDE. Recommendations of the International Task Force for Disease Eradication. MMWR Recomm. Rep. 42 (1993) 1-25
4. Molyneux D.H., and Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Ann. Trop. Med. Parasitol. 96 Suppl. 2 (2002) S15-S40
5. Ramzy R.M., et al. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367 (2006) 992-999
6. Ottesen E., et al. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol. Today 15 (1999) 382-386
7. Molyneux D.H., et al. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol. 19 (2003) 516-522
8. Heukelbach J., et al. Selective mass treatment with ivermectin to control intestinal helminthiases and skin diseases in a severely infected population Bull. WHO 82 (2004) 563-571
9. Lawrence G., et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull. WHO 83 (2005) 34-42
10. WHO (2002) Preparing and implementing a national plan to eliminate lymphatic filariasis. WHO/CDS/CPE/CEE/2000.15 (http://www.who.int)
11. Ottesen E.A. The global programme to eliminate lymphatic filariasis. Trop. Med. Int. Health 5 (2000) 591-594
12. WHO (2002) The global elimination of lymphatic filariasis: the story of Zanzibar. WHO/CDS/CPS/SMT/2002.15 (http://www.who.int)
13. McLaughlin S.I., et al. Frequency, severity and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole, Leogane, Haiti, 2000. Am. J. Trop. Med. Hyg. 68 (2003) 568-573
14. WHO. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis. Wkly Epidemiol. Rec. 79 (2004) 358-365
15. Michael E., et al. Mathematical modeling and control of lymphatic filariasis. Lancet Infect. Dis. 4 (2004) 223-234
16. WHO (2003) Learner's guide: training module on community home-based prevention of disability due to lymphatic filariasis. WHO/CDS/CPE/CEE/2003.35 (http://www.who.int)
17. WHO. Lymphatic filariasis, progress of disability prevention activities. Wkly Epidemiol. Rec. 79 (2004) 417-424
18. Stolk W.A., et al. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J. Infect. Dis. 188 (2003) 1371-1381
19. Oqueka T., et al. Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island. Indonesia. Filaria J. 4 (2005) 5
20. Beau De Rochars M., et al. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am. J. Trop. Med. Hyg. 71 (2004) 466-470
21. Mani T.R., et al. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme. Trop. Med. Int. Health 9 (2004) 1030-1035
22. Mani T.R., et al. Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India. Trop. Med. Int. Health 7 (2002) 541-548